Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ADGRL1 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | C19orf45 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
mRNA | SBDS | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-08 |
mRNA | CPSF6 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | ZNF428 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
mRNA | NUCKS1 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
mRNA | WDR82 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | SRP9 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
mRNA | USP42 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
mRNA | SMAD4 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |